Home » Newsletters » BioWorld Science

BioWorld Science

Feb. 14, 2000

View Archived Issues

Meditech and Immune Network sign license option

Vion licenses potential HBV/HIV therapy to Achillion

IND filing in sight for new oral contraceptive

p38 MAPK inhibitor assessed in rat adjuvant-induced arthritis

Scios reviews 1999 developments

OxiGene highlights promising CA4P developments from Q4 and full year 1999

Generex initiates oral insulin trials in England

ID Biomedical's GAS vaccine well tolerated in early clinical testing

PPL Therapeutics' transgenic AAT shows promising results in phase II

Pharmacia & Upjohn in discussions with FDA regarding Vestra NDA

Major European introduction for Merck's COX-2 inhibitor

Microbiotix and BioChem Pharma to develop novel antibiotic agents

Miacalcin nasal spray receives Canadian approval as treatment for osteoporosis

Metabasis Therapeutics extends diabetes collaboration with Sankyo

Sulfonamide-based inhibitors of TNF-alpha production synthesized at Shionogi

New immunosuppressive agents derived from LK6-A

AHP prepares new rapamycin derivatives

SCRAS presents new class of NOS inhibitors and antioxidants

ORL1 antagonist J-113397 also being explored for cognition enhancement

Next-generation HBOCs in preclinical development at Hemosol

FDA issues approvable letter for Visudyne

UroGen cleared to begin phase I human clinical trial of gene therapy for hemophilia A

Clearance to begin clinical trial of novel acne treatment sought by Praxis

Preclinical studies support potential new indication for tamsulosin

FDA approves Actimmune for treatment of osteopetrosis

Novel Warner-Lambert compounds act as inhibitors of Lp(a) production

Components of naturally occurring antimicrobial complex isolated at Schering-Plough

Focal cerebral ischemic injury in rats improved by broad-spectrum ion channel blocker

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 30, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...